These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 22771132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan.
    Kaneishi K, Nishimura K, Sakurai N, Imai K, Matsuo N, Takahashi N, Okamoto K, Suga A, Sano H, Maeda I, Nishina H, Yamaguchi T, Morita T, Iwase S.
    Support Care Cancer; 2016 Jun; 24(6):2393-5. PubMed ID: 26838020
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
    Mystakidou K, Tsilika E, Kalaidopoulou O, Chondros K, Georgaki S, Papadimitriou L.
    Anticancer Res; 2002 Jun; 22(2B):1187-92. PubMed ID: 12168923
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Olanzapine for nausea and vomiting.
    Licup N.
    Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine versus Metoclopramide for Treatment of Nausea and Vomiting in Advanced Cancer Patients with Incomplete Malignant Bowel Obstruction.
    Kaneishi K, Imai K, Nishimura K, Sakurai N, Kohara H, Ishiki H, Kanai Y, Oyamada S, Yamaguchi T, Morita T, Iwase S.
    J Palliat Med; 2020 Jul; 23(7):880-881. PubMed ID: 32609610
    [No Abstract] [Full Text] [Related]

  • 8. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
    Srivastava M, Brito-Dellan N, Davis MP, Leach M, Lagman R.
    J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature.
    Langley-DeGroot M, Ma JD, Hirst J, Roeland EJ.
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):148-52. PubMed ID: 26095486
    [Abstract] [Full Text] [Related]

  • 10. Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study.
    Harder S, Groenvold M, Isaksen J, Sigaard J, Frandsen KB, Neergaard MA, Mondrup L, Herrstedt J.
    Support Care Cancer; 2019 Aug; 27(8):2849-2856. PubMed ID: 30552594
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy.
    Atkinson SR.
    J Palliat Med; 2014 May; 17(5):503-4. PubMed ID: 24708452
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
    Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, Kizawa Y, Maeno T, Shima Y, Hyodo I.
    Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
    [Abstract] [Full Text] [Related]

  • 14. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: a randomized, double-blind, placebo-controlled study.
    Mizukami N, Yamauchi M, Koike K, Watanabe A, Ichihara K, Masumori N, Yamakage M.
    J Pain Symptom Manage; 2014 Mar; 47(3):542-50. PubMed ID: 23856100
    [Abstract] [Full Text] [Related]

  • 15. A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain.
    Passik SD, Lundberg J, Kirsh KL, Theobald D, Donaghy K, Holtsclaw E, Cooper M, Dugan W.
    J Pain Symptom Manage; 2002 Jun; 23(6):526-32. PubMed ID: 12067777
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial.
    Navari RM, Pywell CM, Le-Rademacher JG, White P, Dodge AB, Albany C, Loprinzi CL.
    JAMA Oncol; 2020 Jun 01; 6(6):895-899. PubMed ID: 32379269
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
    Mystakidou K, Befon S, Liossi C, Vlachos L.
    Cancer; 1998 Sep 15; 83(6):1214-23. PubMed ID: 9740088
    [Abstract] [Full Text] [Related]

  • 18. Effects of low-dose olanzapine on duloxetine-related nausea and vomiting for the treatment of major depressive disorder.
    Zhong Z, Zhang Y, Han H, Huang Z, Wang J, Chen M, Zhang J.
    J Clin Psychopharmacol; 2014 Aug 15; 34(4):495-8. PubMed ID: 24943388
    [Abstract] [Full Text] [Related]

  • 19. Abdominal cancer, nausea, and vomiting.
    Muir JC, von Gunten CF.
    J Palliat Med; 2001 Aug 15; 4(3):391-4. PubMed ID: 11596551
    [Abstract] [Full Text] [Related]

  • 20. The Benefits of Olanzapine in Palliating Symptoms.
    Davis MP, Sanger GJ.
    Curr Treat Options Oncol; 2020 Nov 26; 22(1):5. PubMed ID: 33244634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.